Randomized Controlled Trial Comparing Gastrectomy Plus Chemotherapy with Chemotherapy Alone in Advanced Gastric Cancer with A Single Non-curable Factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01
Open Access
- 9 July 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 38 (7) , 504-506
- https://doi.org/10.1093/jjco/hyn058
Abstract
A randomized controlled trial has started in both Japan and Korea to evaluate the role of gastrectomy in the management of incurable advanced gastric cancer (AGC). Patients with AGC diagnosed as having a single non-curable factor are randomized to gastrectomy plus chemotherapy or chemotherapy alone. Surgeons at 33 specialized centers in Japan and at 15 high-volume hospitals in Korea will recruit 330 patients. Primary end-point is overall survival, and secondary end-points are progression-free survival and adverse events associated with either gastrectomy or chemotherapy.Keywords
This publication has 6 references indexed in Scilit:
- Value of palliative resection in gastric cancerBritish Journal of Surgery, 2002
- Japanese Classification of Gastric Carcinoma – 2nd English Edition –Gastric Cancer, 1998
- Therapeutic significance of palliative operations for gastric cancer for survival and quality of lifeJournal of Surgical Oncology, 1998
- The survival benefit of resection in patients with advanced stomach cancer: The norwegian multicenter experienceWorld Journal of Surgery, 1989
- Palliative resection in gastric cancerJournal of Surgical Oncology, 1983
- Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasisThe American Journal of Surgery, 1980